Clinical Trials Logo

Diabetic Foot Ulcer clinical trials

View clinical trials related to Diabetic Foot Ulcer.

Filter by:

NCT ID: NCT00935051 Completed - Diabetic Foot Ulcer Clinical Trials

Matrix Metalloproteinase-1/Tissue Inhibitor of Metalloproteinase-1 (MMP-1/TIMP-1) Ratio and Diabetic Foot Ulcers

DIAB-MMP2
Start date: May 2009
Phase: Phase 0
Study type: Interventional

The primary objective of this study is to assess the sensitivity and specificity of a MMP-1/TIMP-1 ratio equal to 0.24 at study entry to predict wound healing at 12 weeks' follow up visit.

NCT ID: NCT00915486 Completed - Diabetic Foot Ulcer Clinical Trials

A Dose Finding Study of Topically Applied I-020201 as an Adjunct to Good Standard-of-care in Patients With Chronic Diabetic Foot Ulcers

DFU
Start date: May 2009
Phase: Phase 2
Study type: Interventional

Although major improvements in the management and treatment of diabetic foot ulcers have been made, the clinical and financial burden of such long-term wounds is still high and is likely to increase as the general population ages. The large population affected by diabetic foot ulcers and the high rates of failure ending with amputation even with the best therapeutic regimens have resulted in the development of new therapies. I-020201 is a bioactive therapy intended for topical treatment of hard-to-heal diabetic foot ulcers, stimulating the granulation tissue formation. This study aims to evaluate the safety and efficacy of I-020201 in adjunct to good standard of care in patients with chronic diabetic foot ulcer.

NCT ID: NCT00765063 Completed - Diabetic Foot Ulcer Clinical Trials

The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients (A6301086)

Start date: October 2008
Phase: Phase 2/Phase 3
Study type: Interventional

The primary objective of this 6 month open-label extension trial is to evaluate long-term safety and tolerability of dalteparin in treatment of chronic neuroischaemic foot ulcers in diabetic patients with peripheral arterial occlusive disease (PAOD) and peripheral neuropathy.

NCT ID: NCT00764361 Completed - Diabetic Foot Ulcer Clinical Trials

Safety Study of Topical Doxycycline Gel for Adult Diabetic Lower Extremity Ulcers

Start date: January 2009
Phase: Phase 2
Study type: Interventional

This study is a double-blind, one center, two-arm study with a two (2) week Run-In, evaluating the efficacy of a once-daily administration of NanoDOX™ Hydrogel topically applied to diabetic ulcers in concert with professionally administered Standard of Care (SOC) procedures as described by Standard Operating Procedure(s) of the Department of Veterans Administration Hospitals. During the run-in period patients with infected wounds will receive oral antibiotic and not be included in the topical portion of the study until the infection is shown by wound fluid analysis to be resolved. Following a two (2) week Run-In of all patients to receive SOC treatment for diabetic ulcers, patients would have either the investigational material or the placebo hydrogel applied as a part of their wound care. Each patient would receive 1.5 gm packets of either the test article or the placebo hydrogel for a once-daily home treatment accompanied by a dressing change.

NCT ID: NCT00719251 Completed - Diabetic Foot Ulcer Clinical Trials

Effects of High Voltage Pulsed Current (HVPC) and Low Level Laser Therapy (LLLT) on Wound Healing in Diabetic Ulcers

Start date: March 2004
Phase: N/A
Study type: Interventional

The purpose of this study was to compare the effects of high voltage pulsed current and low level laser therapy on the healing process of diabetic foot ulcers.

NCT ID: NCT00662831 Completed - Diabetic Foot Ulcer Clinical Trials

Study Of The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients

FEENICS
Start date: April 2008
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of the study isto see the effect of Fragmin on the healing of diabetic foot ulcers by determining the number of subjects with ≥50% reduction in ulcer surface area including intact skin healing.

NCT ID: NCT00659646 Completed - Diabetic Foot Ulcer Clinical Trials

The Safety and Efficacy of an Antibiotic Sponge in Diabetic Patients With Moderately Infected Foot Ulcers

Start date: April 2008
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether the gentamicin-collagen sponge when combined with standard daily wound care and an oral antibiotic (levofloxacin) is safe and effective in treating moderately infected skin ulcers compared to treatment only with standard daily wound care and an oral antibiotic (levofloxacin).

NCT ID: NCT00593567 Completed - Diabetic Foot Ulcer Clinical Trials

Safety and Efficacy of an Antibiotic Sponge in Diabetic Patients With a Mild Infection of a Foot Ulcer

Start date: December 2007
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether the gentamicin-collagen sponge when combined with standard of daily wound care is safe and effective in treating mildly infected skin ulcers compared to treatment with an oral antibiotic (levofloxacin) and standard daily wound care.

NCT ID: NCT00477022 Completed - Diabetic Foot Ulcer Clinical Trials

The Effects of Vacuum-Compression Therapy on the Healing of Diabetic Foot Ulcers

VCT
Start date: February 2006
Phase: N/A
Study type: Interventional

the objective of this study is to evaluate the impact of vacuum-compression effects of Vasotrain on the diabetic foot ulcers using stereological method based on Cavalieri’s principle in diabetic patients.

NCT ID: NCT00393510 Completed - Diabetic Foot Ulcer Clinical Trials

Herbal Preparation Used as Adjuvant Therapy on Diabetic Ulcers

Start date: November 2000
Phase: Phase 2
Study type: Interventional

Chronic foot ulcers occurring among diabetic patients are difficult to heal. The frequent elderly age with co-morbidities, vascular insufficiencies, peripheral neuropathies and super imposed infections, all contribute towards the chronicity and failure of treatment. Preserving the ulcerated limb is the patients' wish. On the other hand, an infected ulcer that never heals just unnecessarily prolongs suffering. Nevertheless, patients earnestly like to try all methods of healing before accepting amputation. Objective:To determine whether a course of herbal preparation used as an adjuvant therapy for diabetic patients suffering from chronic foot ulcers may promote healing so that major leg amputation can be avoided.